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Reverse transcriptase (RT) is one of the primary targets for antiretroviral therapy. At first, it 
is related to the lower speed of resistance development for reverse transcriptase inhibitors (RTI) 
comparing to other classes of antiretroviral drugs [1]. Secondly, RTIs act in early stages of 
interaction between virus particle and host cell helping to prevent virus replication [2]. 
Computational methods of drug development became very important for the search of new 
drugs [3] including antiretrovirals [4]. Building models with those methods commonly requires 
usage of samples taken from commercially or publicly available databases (for example ChEMBL). 
However, data on biological activity varies even within one database especially if different testing 
protocols were used. It can cause decreasing of computational model accuracy and make difficult to 
estimate the model’s predictivity. 
We have built quantitative structure-activity relationships (QSAR) models for HIV-1 RTIs 
using data on the biological activity of compounds taken from commercially available Thomson 
Reuters Integrity and freely accessible ChEMBL databases. QSAR model prediction accuracy was 
closely related to the way how the data sets were formed. Samples combined based on the only 
target, and quantitative characteristic of biological activity information showed poor accuracy. The 
data sets prepared taking into account the type of assay (similar biological material and method of 
experimental testing used to determine the biological activity of compounds) lead to more accurate 
models. 
The purpose of our study is to develop and validate method that will allow creating 
homogeneous sample suitable for building accurate and predictive QSAR models. Over 150 relevant 
scientific publications were chosen from PubMed database. Then, their contents were converted 
from PDF to text format with using PDFLib TET tool. Obtained text was processed through 
Lingpipe 4.1.0 Java libraries and Python 2.6 scripts to select text parts containing biological assay 
description, prepare data sets containing feature vectors received for each biological assay and 
further prediction of class affiliation in relation with the biological assay. The value of mean 
balanced accuracy obtained during the preliminary testing was about 86%. The results of QSAR 
models creation based on the homogeneous data sets will be discussed. Classification of HIV-1 RTIs 
testing methods will be presented. 
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